Retinoblastoma expression in thyroid neoplasms

被引:28
作者
Anwar, F
Emond, MJ
Schmidt, RA
Hwang, HC
Bronner, MP
机构
[1] Univ Washington, Dept Pathol, Seattle, WA 98195 USA
[2] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
关键词
immunohistochemistry; nodular goiter; paraffin-embedded tissue; retinoblastoma; thyroid neoplasm;
D O I
10.1038/modpathol.3880097
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Retinoblastoma (Rb) mutation in thyroid neoplasia has been identified in a few molecular studies; however, the utility of Rb immunohistochemistry in distinguishing benign and malignant thyroid lesions has not been documented in formalin-fixed, paraffin-embedded tissues. The present study investigated Rb immunohistochemistry in a series of 111 formalin-fixed, paraffin-embedded benign and malignant thyroid lesions. All of the major histologic subtypes were included to detect any heterogeneity in Rb-l expression that might influence the diagnostic utility of this technique or further elucidate the pathogenesis of thyroid neoplasia among the categories. Altogether, 34 follicular adenomas, 9 follicular carcinomas, 7 Hurthle cell adenomas, 5 Hurthle cell carcinomas, 23 papillary carcinomas (8 of which were follicular variants), 4 insular carcinomas, 4 anaplastic carcinomas, 6 medullary carcinomas, and 19 nodular goiters were analyzed. Avidin-biotin immunohistochemistry was performed using the Dako Rb-l clone. Pronase digestion was introduced into the epitope retrieval protocol to eliminate false-positive cytoplasmic staining. Nuclear immunoreactivity was assessed as positive if 10% or more of thyroid epithelial nuclei stained positively, and conversely as negative. The majority of benign non-Hurthle thyroid lesions, whether hyperplastic or neoplastic, retained Rb nuclear immunopositivity in most cells (51 of 53 cases [96%]). Conversely, malignant thyroid neoplasms lacked Rib immunoreactivity in the majority (42 of 51 cases [82%]), including all papillary carcinomas (23 of 23) and almost all follicular carcinomas (8 of 9 [89%]). Virtually all Hurthle cell neoplasms were negative (11 of Ii [92%]), whether benign or malignant. In conclusion, Rb imnunohistochemistry can aid in the distinction between benign and malignant thyroid lesions in conjunction with morphology. This seems to be most applicable to the often problematic differentiation between follicular adenoma and the follicular Variant of papillary carcinoma (P <.0001; sensitivity and specificity, 100%) or minimally invasive follicular carcinoma (P = .0007; sensitivity, 89%; specificity, 100%).
引用
收藏
页码:562 / 569
页数:8
相关论文
共 45 条
[21]  
Ichimura K, 1996, ONCOGENE, V13, P1065
[22]  
Kashima K, 1997, MODERN PATHOL, V10, P515
[23]   MUTATION AND CHILDHOOD CANCER - PROBABILISTIC MODEL FOR INCIDENCE OF RETINOBLASTOMA [J].
KNUDSON, AG ;
HETHCOTE, HW ;
BROWN, BW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (12) :5116-5120
[24]  
KNUDSON AG, 1975, CANCER, V35, P1022, DOI 10.1002/1097-0142(197503)35:3+<1022::AID-CNCR2820350726>3.0.CO
[25]  
2-A
[26]   CHROMOSOMAL DELETION AND RETINOBLASTOMA [J].
KNUDSON, AG ;
MEADOWS, AT ;
NICHOLS, WW ;
HILL, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (20) :1120-1123
[27]   RBP1 induces growth arrest by repression of E2F-dependent transcription [J].
Lai, A ;
Marcellus, RC ;
Corbeil, HB ;
Branton, PE .
ONCOGENE, 1999, 18 (12) :2091-2100
[28]   THE RETINOBLASTOMA SUSCEPTIBILITY GENE ENCODES A NUCLEAR PHOSPHOPROTEIN ASSOCIATED WITH DNA-BINDING ACTIVITY [J].
LEE, WH ;
SHEW, JY ;
HONG, FD ;
SERY, TW ;
DONOSO, LA ;
YOUNG, LJ ;
BOOKSTEIN, R ;
LEE, EYHP .
NATURE, 1987, 329 (6140) :642-645
[29]  
LEMOINE NR, 1989, ONCOGENE, V4, P159
[30]  
Livolsi V A, 1981, Pathol Annu, V16, P357